DECLARE Logo        DECLARE Enrollment

  Glaucoma Drainage Device and Endothelial Cell Density Loss Compare (DECLARE) Trial

 Enrollment in the DECLARE Trial

  • Open to people ages 18 years and up.
  •  Medically uncontrolled glaucoma requiring GDD or GDD combined with phacoemulsification as the planned surgical procedure 
  • Candidate for GDD implantation for ciliary sulcus and AC tube

 

Open Enrollment

You Cannot Join If...

  • Preexisting corneal condition that would affect the corneal endothelium or previous corneal transplant
  • Presence or history of Cypass Micro-stent
  • Presence of GDD implant, Xen Gel Stent, or Preserflo MicroShunt or previous GDD implant, Xen Gel Stent, or Preserflo MicroShunt removed within the past 6 months
  • Previous trabeculectomy and/or minimally invasive glaucoma surgery within the past 6 months
  • AC intraocular lens
  • Presence of nanophthalmos, uncontrolled uveitis, silicone oil, Sturge-Weber syndrome or other conditions associated with elevated episcleral venous pressure
  • Unwilling or unable to give consent, unwilling to accept randomization, or unable to return for scheduled protocol visits
  • No light perception vision in the study eye or fellow eye visual acuity < 20/200
  • Need for glaucoma surgery combined with other ocular procedures (i.e. corneal transplant, or retinal surgery) or anticipated need for additional ocular surgery
test
Clinicaltrials.gov ID: NCT05924477
Home
About DECLARE